Outcome of the Rights issue Committee Meeting held on 28-04-2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Indrayani Biotech Ltd's Rights Issue Committee met on April 28, 2026 and approved key documents for the proposed rights issue. The committee cleared the Letter of Offer (LOF) and Abridged Letter of Offer (ALOF), which are the offer documents shareholders will receive. It also approved the Composite Application Form (CAF) format along with instructions for the renunciation process, allowing shareholders to either subscribe themselves or transfer their rights to others. This meeting outcome signals the rights issue is moving forward in its execution timeline.
Shareholders can expect to receive the offer documents soon. The rights issue will allow existing shareholders to purchase additional shares, typically at a discount, providing downside protection but also potential dilution.